Suite A · 6450 Kingston Pike, Knoxville TN 37919  ·  (865) 895-9118

Home  /  Peptides & Wellness  /  Sermorelin

Peptide Therapy

Your own growth hormone — stimulated, not replaced.

Sermorelin is a peptide that prompts your pituitary to release the growth hormone you used to make on your own. The pulse pattern is yours. The signal is restored.

Sermorelin is a 29-amino-acid peptide that binds to the same pituitary receptors that natural growth-hormone-releasing hormone binds to. It does not replace your endogenous growth hormone. It asks your pituitary to release it the way it did in your thirties.

For the right patient, the practical result is measurable improvement in deep-sleep architecture, recovery from exercise, lean body composition, and skin quality over a six- to twelve-month protocol.

Who it’s for

Adults — most often in their forties through sixties — whose recovery, sleep, body composition, or overall vitality have shifted in ways that don’t respond to lifestyle work alone. We confirm candidacy with baseline labs that include IGF-1, a thyroid panel, and a metabolic profile.

How the protocol works

Sermorelin is administered as a small evening sub-cutaneous injection — typically five nights per week. The timing is deliberate: it leverages the body’s natural overnight growth-hormone pulse rather than working against it. Patients almost universally report sleep changes within the first one to two weeks. Body-composition and recovery effects develop over months.

Pharmaceutical-grade sourcing

Our sermorelin is sourced from licensed U.S. compounding pharmacies operating under 503A or 503B oversight, with certificates of analysis available for any patient who’d like to see them. The molecule in your vial is the molecule on the label — every time.

What to expect

Begin with a conversation

Every patient starts with a private consultation and baseline labs. We’ll talk through your goals, confirm fit, and design a protocol that builds momentum from week one. By appointment.

Call (865) 895-9118 Request a Consultation

Sources

  1. Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging. 2006;1(4):307-308. pubmed.ncbi.nlm.nih.gov/18046908
  2. Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews. 2018;6(1):45-53. pubmed.ncbi.nlm.nih.gov/28526632

Text Us

Leave us a message — we’ll text you back same business day.

By submitting you agree to be contacted about your inquiry.